Pfizer Inc. recalls Lyrica (pregabalin) capsules, 50 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY…
- Recall date
- January 11, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0648-2016
- FDA classification
- Class II
- Brand / firm
- Pfizer Inc.
- Sold / distributed
- Nationwide and Puerto Rico
Why it was recalled
FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Lyrica (pregabalin) capsules, 50 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1013-68
Get recall alerts
Free email alert whenever Pfizer Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pfizer Inc.